Tilray Inc (TLRY)
Healthcare
Drug Manufacturers - Specialty & Generic
4.60 $
+2.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -69 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5 | -0.6 | -4.5 | -5.9 | -47 | -250 | -54 | -177 | 7.9 | -42 | -130 | -69 | |
| 0.2 | 0.6 | 2.6 | 1.8 | 3.6 | 15 | 82 | 155 | 130 | 173 | 183 | 68 | |
| 0.8 | 0.3 | 1.8 | 14 | 19 | 18 | 17 | 36 | 40 | 32 | 24 | 46 | |
| -1.5 | -0.9 | 2.3 | 0.3 | -14 | -117 | -61 | -92 | 14 | -12 | -86 | -87 | |
| 1.6 | 2.6 | 0.7 | 11 | 51 | 71 | 47 | 34 | 21 | 40 | 45 | 33 | |
| -2.0 | -3.5 | -1.4 | -12 | -99 | -245 | 56 | -22 | -285 | 175 | -64 | -56 | |
| – | – | – | – | – | – | – | 7,484 | 81 | – | 1.5 | – | |
| – | – | – | – | – | -4.9 | 0.0 | -1.2 | -1.2 | 0.0 | 0.0 | -0.2 | |
| – | – | – | – | – | – | – | -124 | -58 | -84 | -26 | -29 | |
| 9.9 | 9.6 | 15 | 12 | 636 | 111 | 150 | 128 | 70 | -102 | 183 | 131 | |
| 4.4 | 5.5 | 10 | -5.1 | 489 | -379 | 473 | -73 | -209 | 30 | -9.2 | 7.7 | |
| -5.1 | -3.2 | -5.1 | -17 | -97 | -322 | -101 | -211 | -13 | -82 | -175 | -102 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.